Eliem Therapeutics, Inc.

NASDAQ:ELYM

7.98 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 223.14105.03193.11257.35325.29434.43743.58535.94432.60231.93146.92262.81999.48247.91120.487-21.223
Short Term Investments 0013.68650.0877.33974.93579.98186.67590.34992.0189.55883.19900042.446
Cash and Short Term Investments 223.14105.031106.798107.433102.633109.372123.566122.619122.951123.941136.48146.01899.48247.91120.48721.223
Net Receivables 02.0212.0241.9226.8656.5876.4925.0665.8516.5236.5236.9432.5412.53500
Inventory 0002.4784.117-7.208-6.4924.9313.1722.219-6.5234.6212.3221.48300
Other Current Assets 2.8571.2191.4330.6010.6290.62110.8270.5551.1020.60.8521.050.4580.6080.0110
Total Current Assets 225.997108.271110.255112.434114.244109.372134.393133.171133.076133.283148.252158.632104.80352.53721.99821.223
Non-Current Assets:
Property, Plant & Equipment, Net 0.0210.1110.1990.2860.3720.6620.4710.5850.6970.807000000
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 00000006.96111.70125.91124.91923.6190000
Tax Assets 0000000000000000
Other Non-Current Assets -00.9520.0150.0151.65812.0510.1280.1414.6312.4180.0702.8241.1492.633-21.223
Total Non-Current Assets 0.0211.0630.2140.3012.0312.7130.5997.68717.02929.13624.98923.6192.8241.1492.633-21.223
Total Assets 226.018109.334110.469112.735116.274122.085134.992140.858150.105162.419173.241182.251107.62753.68624.6310
Liabilities & Equity:
Current Liabilities:
Account Payables 0.5090.0850.0660.7360.8780.8640.751.4941.0610.8471.4042.5791.9552.0031.0860
Short Term Debt 0.10.2250.3340.4010.4850.4640.30.3520.4390.459000000
Tax Payables 0000000000000000
Deferred Revenue -0.509-0.085-0.0660000000000000
Other Current Liabilities 3.6412.7252.4991.7642.2553.5875.0474.4346.1145.594.6273.0113.7582.0671.9770
Total Current Liabilities 3.7412.952.8332.9013.6184.9156.0976.287.6146.8966.0315.595.7134.073.0630
Non-Current Liabilities:
Long Term Debt 000.0150.0580.10.2230.180.2190.2560.381000000
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 000.0220.0340.0550.08700000.00700000
Total Non-Current Liabilities 000.0370.0920.1550.310.180.2190.2560.3810.00700000
Total Liabilities 3.7412.952.872.9933.7735.2256.2776.4997.877.2776.0385.595.7134.073.0630
Equity:
Preferred Stock 00000000000182.251152.75992.79846.55126.174
Common Stock 0.0070.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.0010.0010.0010
Retained Earnings -212.565-157.676-155.979-152.338-148.37-143.15-120.86-113.098-103.416-88.82-75.616-65.071-55.456-46.737-28.1360
Accumulated Other Comprehensive Income/Loss 0-0-0.002-0.011-0.035-0.095-0.358-0.581-0.604-0.521-0.123-0.01800-0-5.562
Other Total Stockholders Equity 434.835264.057263.577262.088260.903260.102249.93248.035246.252244.48242.93959.4964.613.5543.1520
Total Shareholders Equity 222.277106.384107.599109.742112.501116.86128.715134.359142.235155.142167.203176.661101.91449.61621.56820.612
Total Equity 222.277106.384107.599109.742112.501116.86128.715134.359142.235155.142167.203176.661101.91449.61621.56820.612
Total Liabilities & Shareholders Equity 226.018109.334110.469112.735116.274122.085134.992140.858150.105162.419173.241182.251107.62753.68624.63120.612